Terms: = Prostate cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
22 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer.
Cen S; Jiang D; Lv D; Xu R; Hou J; Yang Z; Wu P; Xiong X; Gao X
Front Endocrinol (Lausanne); 2023; 14():1090277. PubMed ID: 36967783
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
4. Lectin Affinity Chromatography for the Discovery of Novel cancer Glycobiomarkers: A Case Study with PSA Glycoforms and prostate cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract] [Full Text] [Related]
5. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
6. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
7. Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis.
Jiang H; Guo S; Zhao Y; Wang Y; Piao HY; Wu Y; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152569. PubMed ID: 31421977
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of MARK BTM for Quantitative Measurement of Three Tumor Markers: prostate Specific Antigen, Alpha Fetoprotein, and Carcinoembryonic Antigen.
Hwang H; Kim J; Choi J; Kim KH; Han HS
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414747
[TBL] [Abstract] [Full Text] [Related]
9. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
[TBL] [Abstract] [Full Text] [Related]
10. Transcriptome Analysis of WHV/c-myc Transgenic Mice Implicates Cytochrome P450 Enzyme 17A1 as a Promising Biomarker for Hepatocellular Carcinoma.
Wang F; Huang J; Zhu Z; Ma X; Cao L; Zhang Y; Chen W; Dong Y
Cancer Prev Res (Phila); 2016 Sep; 9(9):739-49. PubMed ID: 27339169
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort.
Bevilacqua V; Chan MK; Chen Y; Armbruster D; Schodin B; Adeli K
Clin Chem; 2014 Dec; 60(12):1532-42. PubMed ID: 25261558
[TBL] [Abstract] [Full Text] [Related]
12. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract] [Full Text] [Related]
13. Serotonin used as prognostic marker of urological tumors.
Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
[TBL] [Abstract] [Full Text] [Related]
14. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract] [Full Text] [Related]
15. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
Canil CM; Tannock IF
Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
[TBL] [Abstract] [Full Text] [Related]
16. Clinical uses of tumor markers: a critical review.
Duffy MJ
Crit Rev Clin Lab Sci; 2001 Jun; 38(3):225-62. PubMed ID: 11451209
[TBL] [Abstract] [Full Text] [Related]
17. prognosis of primary testicular seminoma: a report on 57 new cases.
Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
[TBL] [Abstract] [Full Text] [Related]
18. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract] [Full Text] [Related]
19. Three cases of extrapulmonary small cell carcinoma occurring in the prostate, stomach, and pancreas.
Morikawa T; Kobayashi S; Yamadori I; Okino T; Hirakawa E; Kurose A; Ohmori M; Kobayashi M
Indian J Cancer; 1994 Dec; 31(4):268-73. PubMed ID: 7533131
[TBL] [Abstract] [Full Text] [Related]
20. Metastasis of unknown origin.
Perchalski JE; Hall KL; Dewar MA
Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
[TBL] [Abstract] [Full Text] [Related]
[Next]